Latest News about GSK
Recent news which mentions GSK
Is Merck Moving Toward Another Blockbuster Drug Launch?
October 26, 2022
From Motley Fool
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
From Benzinga
From Benzinga
Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids
October 21, 2022
From Benzinga
From Benzinga
3 Things the Smartest Investors Know About This Beaten-Down Stock
October 20, 2022
From Motley Fool
7 Quality Stocks Selling at a Discount as Q4 Kicks Off
October 19, 2022
From InvestorPlace
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
October 19, 2022
From Benzinga
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
October 17, 2022
From Benzinga
From Benzinga
From Benzinga
Tickers
GSK
From MarketWatch
FDA Approves GSK's Whooping Cough Vaccine During Pregnancy For Prevention In Infants
October 10, 2022
Tickers
GSK
From Benzinga
Want $1,000 in Passive Income? Don't Make These 3 Mistakes
October 07, 2022
From Motley Fool
From MarketWatch
From Motley Fool
AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial
October 05, 2022
From Benzinga
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
This Is the Best Time to Buy These 7 Long-Term Dividend Stocks
October 03, 2022
From InvestorPlace
From Benzinga
7 Consumer Stocks to Sell Before They Die
September 28, 2022
From InvestorPlace
2 High Yielders Decimated By The Russia-Ukraine War: Is Now The Time To Buy?
September 27, 2022
From Benzinga
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
September 26, 2022
From Benzinga
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
From Benzinga
Unilever CEO Alan Jope To Retire Next Year
September 26, 2022
From Benzinga
7 Stocks to Buy That Can Soar in Good Times or in Bad
September 22, 2022
From InvestorPlace
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
September 22, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.